UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Humacyte
HUMA
$194M
| $596K | ﹤0.01% |
+109,542
| New | +$722K |
|
2552
Digimarc Corp
DMRC
$178M
| $594K | ﹤0.01% |
22,114
-3,414
| -13% | -$101K |
|
2553
Tyra Biosciences
TYRA
$1.58B
| $593K | ﹤0.01% |
+25,209
| New | +$529K |
|
2554
Standard BioTools
LAB
$314M
| $592K | ﹤0.01% |
306,871
-75,617
| -20% | -$148K |
|
2555
Pulse Biosciences
PLSE
$3.02B
| $588K | ﹤0.01% |
+33,535
| New | +$572K |
|
2556
FuboTV Inc
FUBO
$273M
| $587K | ﹤0.01% |
34,464
-8,947
| -21% | -$161K |
|
|
YMAB
2557
DELISTED
Y-mAbs Therapeutics
YMAB
| $586K | ﹤0.01% |
44,591
-13,708
| -24% | -$174K |
|
2558
Tango Therapeutics
TNGX
$4.41B
| $580K | ﹤0.01% |
75,302
-3,420
| -4% | -$32.6K |
|
|
TUYA
2559
Tuya Inc
TUYA
$1.1B
| $578K | ﹤0.01% |
350,116
+132,200
| +61% | +$202K |
|
|
ITOS
2560
DELISTED
iTeos Therapeutics
ITOS
| $577K | ﹤0.01% |
56,507
-2,333
| -4% | -$35.6K |
|
2561
Community Trust Bancorp
CTBI
$1.41B
| $572K | ﹤0.01% |
11,525
-2,453
| -18% | -$117K |
|
|
VERV
2562
DELISTED
Verve Therapeutics
VERV
| $557K | ﹤0.01% |
115,041
+6,595
| +6% | +$38.3K |
|
|
STKL
2563
DELISTED
SunOpta
STKL
| $555K | ﹤0.01% |
87,002
-232,339
| -73% | -$1.36M |
|
2564
Navitas Semiconductor
NVTS
$3.63B
| $554K | ﹤0.01% |
226,289
-39,995
| -15% | -$130K |
|
2565
U-Haul Holding Co
UHAL
$14.6B
| $552K | ﹤0.01% |
7,124
-6,732
| -49% | -$460K |
|
|
LAZR
2566
DELISTED
Luminar Technologies
LAZR
| $549K | ﹤0.01% |
40,696
-2,014
| -5% | -$36.5K |
|
2567
EyePoint Inc
EYPT
$1.2B
| $548K | ﹤0.01% |
68,630
-10,616
| -13% | -$93.2K |
|
|
KEEL
2568
Keel Infrastructure Corp
KEEL
$2.34B
| $548K | ﹤0.01% |
259,722
-70,462
| -21% | -$163K |
|
|
SKE
2569
Skeena Resources
SKE
$4.04B
| $547K | ﹤0.01% |
+64,602
| New | +$468K |
|
2570
Rush Enterprises Class B
RUSHB
$6.14B
| $544K | ﹤0.01% |
11,345
-1,665
| -13% | -$75.2K |
|
2571
OmniAb
OABI
$447M
| $542K | ﹤0.01% |
128,202
-15,434
| -11% | -$66.7K |
|
2572
Evolv Technologies
EVLV
$1.1B
| $539K | ﹤0.01% |
133,209
-42,465
| -24% | -$148K |
|
|
CMRC
2573
Commerce.com Inc Series 1
CMRC
$184M
| $539K | ﹤0.01% |
92,149
-26,232
| -22% | -$173K |
|
2574
Savara
SVRA
$1.19B
| $533K | ﹤0.01% |
125,815
+6,141
| +5% | +$27.1K |
|
2575
Kura Sushi USA
KRUS
$593M
| $529K | ﹤0.01% |
6,572
+1,644
| +33% | +$104K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.